electroCore Surges in Recognition, Joins Russell Microcap Index

Published / Modified Jun 11 2024
CSIMarket Team / CSIMarket.com

electroCore Joins Russell Microcap Index as Its Stock Receives Inclusion Nod

In an exciting development for electroCore, Inc., the commercial-stage bioelectronic medicine and wellness company, it has been announced that the company's stock is on the preliminary additions list for inclusion in the prestigious Russell Microcap Index.
The preliminary list, posted by FTSE Russell on May 24, 2024, highlights electroCore's growing prominence in the market and serves as a testament to its potential for further growth and success.

The Russell Microcap Index is an important benchmark within the financial industry that measures the performance of the microcap segment of the U.S.
equity market.
Being part of this index would provide electroCore with enhanced visibility among investors and potentially attract more attention to the company's innovative bioelectronic medicine and wellness solutions.

The inclusion of electroCore's stock in the Russell Microcap Index will take effect after the market closes on June 28, 2024.
The newly reconstituted family of indices will begin trading from July 1, 2024.
This development showcases the confidence of FTSE Russell in electroCore's long-term growth prospects and validates the company's position within the microcap space.

To put these recent developments into context, it is important to consider the current state of electroCore.
At present, electroCore has 6.617 million shares outstanding.
This highlights the company's market reach and potential for shareholder value.
Furthermore, with a current stock price of $6.43, electroCore's inclusion in the Russell Microcap Index could potentially attract more investors, further stimulating the company's growth trajectory.

Overall, electroCore's inclusion in the Russell Microcap Index is a significant recognition of the company's accomplishments.
As a commercial-stage bioelectronic medicine and wellness company, electroCore is driving innovation in the industry and revolutionizing patient care.
This news is likely to boost investor confidence in electroCore's future prospects and help solidify its position within the market.


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com